Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$26.63
+6.9%
$21.40
$17.86
$29.62
$1.22B2604,450 shs1.26 million shs
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$109.17
-4.2%
$118.66
$108.81
$212.00
$3.74B1.33509,827 shs430,659 shs
LivaNova PLC stock logo
LIVN
LivaNova
$73.81
+0.0%
$66.79
$41.01
$75.82
$4.05B0.82838,555 shs763,627 shs
Envista Holdings Corporation stock logo
NVST
Envista
$23.34
-0.9%
$25.36
$17.78
$30.42
$3.80B0.884.15 million shs3.33 million shs
10 Stocks Set to Soar in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
+6.86%+11.19%+25.55%+32.03%+21.99%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-4.15%-6.34%-9.63%-13.25%-22.78%
LivaNova PLC stock logo
LIVN
LivaNova
+0.01%-0.03%+21.00%+7.86%+70.90%
Envista Holdings Corporation stock logo
NVST
Envista
-1.03%-0.27%-11.30%-18.58%+27.62%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$26.63
+6.9%
$21.40
$17.86
$29.62
$1.22B2604,450 shs1.26 million shs
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$109.17
-4.2%
$118.66
$108.81
$212.00
$3.74B1.33509,827 shs430,659 shs
LivaNova PLC stock logo
LIVN
LivaNova
$73.81
+0.0%
$66.79
$41.01
$75.82
$4.05B0.82838,555 shs763,627 shs
Envista Holdings Corporation stock logo
NVST
Envista
$23.34
-0.9%
$25.36
$17.78
$30.42
$3.80B0.884.15 million shs3.33 million shs
10 Stocks Set to Soar in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
+6.86%+11.19%+25.55%+32.03%+21.99%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-4.15%-6.34%-9.63%-13.25%-22.78%
LivaNova PLC stock logo
LIVN
LivaNova
+0.01%-0.03%+21.00%+7.86%+70.90%
Envista Holdings Corporation stock logo
NVST
Envista
-1.03%-0.27%-11.30%-18.58%+27.62%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.40
Hold$32.0020.17% Upside
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2.94
Moderate Buy$189.6973.76% Upside
LivaNova PLC stock logo
LIVN
LivaNova
2.67
Moderate Buy$79.387.54% Upside
Envista Holdings Corporation stock logo
NVST
Envista
2.40
Hold$28.8323.53% Upside

Current Analyst Ratings Breakdown

Latest BLFS, LIVN, IRTC, and NVST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/1/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Lower Price TargetBuy$180.00 ➝ $152.00
6/1/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Reiterated RatingBuy
5/18/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Lower Price TargetBuy$225.00 ➝ $180.00
5/12/2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
DowngradeStrong-BuyHold
5/11/2026
Envista Holdings Corporation stock logo
NVST
Envista
DowngradeHold (C)Hold (C-)
5/7/2026
LivaNova PLC stock logo
LIVN
LivaNova
UpgradeSell (D+)Hold (C)
5/7/2026
Envista Holdings Corporation stock logo
NVST
Envista
Reiterated RatingOutperform$33.00
5/7/2026
LivaNova PLC stock logo
LIVN
LivaNova
Boost Price TargetEqual Weight$73.00 ➝ $76.00
5/7/2026
LivaNova PLC stock logo
LIVN
LivaNova
Boost Price TargetOutperform$85.00 ➝ $90.00
5/7/2026
LivaNova PLC stock logo
LIVN
LivaNova
Lower Price TargetOutperform$78.00 ➝ $76.00
5/7/2026
Envista Holdings Corporation stock logo
NVST
Envista
Boost Price TargetNeutral$26.00 ➝ $29.00
(Data available from 6/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$96.21M13.52$0.24 per share108.83$7.72 per share3.45
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$787.85M4.55N/AN/A$4.74 per share23.03
LivaNova PLC stock logo
LIVN
LivaNova
$1.43B2.83$4.84 per share15.26$21.98 per share3.36
Envista Holdings Corporation stock logo
NVST
Envista
$2.81B1.35$2.15 per share10.85$18.89 per share1.24
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$4.59M-$0.08N/A106.52N/A-2.80%1.81%1.65%8/6/2026 (Estimated)
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$44.55M-$0.86N/A83.34N/A-3.53%-10.26%-1.39%7/30/2026 (Estimated)
LivaNova PLC stock logo
LIVN
LivaNova
-$242.47M$1.9537.8518.09N/A7.48%16.48%7.59%8/5/2026 (Estimated)
Envista Holdings Corporation stock logo
NVST
Envista
$47M$0.4156.9314.961.482.41%7.11%3.91%8/5/2026 (Estimated)

Latest BLFS, LIVN, IRTC, and NVST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$0.01$0.04+$0.03$0.02$25.66 million$27.50 million
5/6/2026Q1 2026
LivaNova PLC stock logo
LIVN
LivaNova
$0.85$0.98+$0.13$0.40$346.05 million$362.26 million
5/6/2026Q1 2026
Envista Holdings Corporation stock logo
NVST
Envista
$0.31$0.36+$0.05$0.23$680.04 millionN/A
4/30/2026Q1 2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$0.56-$0.35+$0.21-$0.43$194.11 million$199.39 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/AN/AN/AN/AN/A
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Envista Holdings Corporation stock logo
NVST
Envista
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/A
7.30
5.50
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
4.03
5.17
4.98
LivaNova PLC stock logo
LIVN
LivaNova
0.24
1.33
1.11
Envista Holdings Corporation stock logo
NVST
Envista
0.47
2.44
2.06

Institutional Ownership

CompanyInstitutional Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
93.24%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/A
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Envista Holdings Corporation stock logo
NVST
Envista
N/A

Insider Ownership

CompanyInsider Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.20%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.98%
LivaNova PLC stock logo
LIVN
LivaNova
0.35%
Envista Holdings Corporation stock logo
NVST
Envista
0.99%
CompanyEmployeesShares OutstandingFree FloatOptionable
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
44048.86 million47.78 millionOptionable
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2,40032.86 million32.54 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
3,30054.93 million54.74 millionOptionable
Envista Holdings Corporation stock logo
NVST
Envista
12,000162.73 million161.12 millionOptionable

Recent News About These Companies

Envista Q1 Earnings Call Highlights
Envista (NVST) Q1 2026 Earnings Transcript
Envista: Q1 Earnings Snapshot

New MarketBeat Followers Over Time

Media Sentiment Over Time

BioLife Solutions stock logo

BioLife Solutions NASDAQ:BLFS

$26.63 +1.71 (+6.86%)
Closing price 06/1/2026 04:00 PM Eastern
Extended Trading
$26.92 +0.29 (+1.07%)
As of 07:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

iRhythm Technologies stock logo

iRhythm Technologies NASDAQ:IRTC

$109.17 -4.73 (-4.15%)
Closing price 06/1/2026 04:00 PM Eastern
Extended Trading
$109.22 +0.05 (+0.05%)
As of 08:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

LivaNova stock logo

LivaNova NASDAQ:LIVN

$73.81 +0.01 (+0.01%)
Closing price 06/1/2026 04:00 PM Eastern
Extended Trading
$74.06 +0.25 (+0.34%)
As of 07:34 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Envista stock logo

Envista NYSE:NVST

$23.34 -0.21 (-0.88%)
Closing price 06/1/2026 03:59 PM Eastern
Extended Trading
$23.36 +0.02 (+0.09%)
As of 07:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.